FDMT insider buying & filings

FDMT4D Molecular Therapeutics, Inc.

NasdaqGS · Healthcare · $760.16M

$13.76

+0.95% · Sep 16

27 insider filings on record.
None of them an open-market buy in the last year.

Last Form 4 Sep 16 · scanned 13m ago

Price · 1Y · daily● 7 sells

▸ hover a marker for the filing · drag to zoom · 4 moves explained

AI brief · from the filings on this pagePro

The filings, the score and the setup on this page, read for you in about ten seconds — what the insiders did, and what stands against it.

Market cap

$760.16M

Float

42.4M

77% public

Short % float

Pro

Price / profit

—

not yet profitable

Price / future profit

—

Price / sales

8.3

The record

newest first

DateTypeInsiderOf stakeShares @ priceValue

Sep 16SELLKirn David10b5-1See Remarksdirect58,333 @ $13.90$811.0K

Sep 3SELLBizily Scott10b5-1Chief Legal Officerdirect584 @ $14.00$8.2K

Sep 3EXERCISEBizily Scott10b5-1Chief Legal Officerdirect584 @ $6.49$3.8K

Aug 17SELLBizily Scott10b5-1Chief Legal Officerdirect1,635 @ $12.20$19.9K

Aug 17EXERCISEBizily Scott10b5-1Chief Legal Officerdirect1,635 @ $4.14$6.8K

The file stays open

▸ SEC EDGAR · FINRA · Nasdaq — public sources only · research, not advice